Literature DB >> 15758653

Mitochondrial dysfunction in hepatitis C.

Masaaki Korenaga1, Michiari Okuda, Kazuhiro Otani, Ting Wang, Yanchun Li, Steven A Weinman.   

Abstract

Chronic hepatitis C induces a state of hepatic oxidative stress that is more pronounced than that present in many other inflammatory liver diseases. This review summarizes recent information that the hepatitis C virus (HCV) core protein plays an important role in this phenomenon. Core protein localizes to mitochondria, particularly at the points of contact between mitochondrial outer membrane and endoplasmic reticulum. Its expression causes inhibition of electron transport at complex I, increased complex I reactive oxygen species (ROS) production, decreased mitochondrial glutathione, and increased mitochondrial permeability transition in response to exogenous oxidants and tumor necrosis factor-alpha. Possible mechanisms of the core protein effects include direct interaction with electron carriers and indirect effects mediated by changes in mitochondrial calcium. These results suggest that antioxidant approaches may prove beneficial for patients with chronic hepatitis C.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15758653     DOI: 10.1097/01.mcg.0000155517.02468.46

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  30 in total

Review 1.  Involvement of autophagy in alcoholic liver injury and hepatitis C pathogenesis.

Authors:  Natalia A Osna; Paul G Thomes; Terrence M Donohue
Journal:  World J Gastroenterol       Date:  2011-05-28       Impact factor: 5.742

Review 2.  Nitric oxide and redox regulation in the liver: Part I. General considerations and redox biology in hepatitis.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-09       Impact factor: 2.192

3.  Coinfection with hepatitis C virus, oxidative stress and antioxidant status in HIV-positive drug users in Miami.

Authors:  M K Baum; S Sales; D T Jayaweera; S Lai; G Bradwin; C Rafie; J B Page; A Campa
Journal:  HIV Med       Date:  2011-02       Impact factor: 3.180

Review 4.  Clinical implications of oxidative stress and antioxidant therapy.

Authors:  Gerald W Dryden; Ion Deaciuc; Gavin Arteel; Craig J McClain
Journal:  Curr Gastroenterol Rep       Date:  2005-08

5.  Mitochondrial complex III deficiency in a case of HCV related noninflammatory myopathy.

Authors:  P Cortelli; J Mandrioli; M Zeviani; R Lodi; C Prata; M Pecorari; G Orlando; G Guaraldi
Journal:  J Neurol       Date:  2007-10-15       Impact factor: 4.849

6.  The requirement of reactive oxygen intermediates for lymphocytic choriomeningitis virus binding and growth.

Authors:  Ryan D Michalek; S Troy Pellom; Beth C Holbrook; Jason M Grayson
Journal:  Virology       Date:  2008-08-08       Impact factor: 3.616

7.  Role of Hepatitis C virus core protein in viral-induced mitochondrial dysfunction.

Authors:  T Wang; R V Campbell; M K Yi; S M Lemon; S A Weinman
Journal:  J Viral Hepat       Date:  2010-11       Impact factor: 3.728

8.  Effects of TAT-conjugated platinum nanoparticles on lifespan of mitochondrial electron transport complex I-deficient Caenorhabditis elegans, nuo-1.

Authors:  Yuri Sakaue; Juewon Kim; Yusei Miyamoto
Journal:  Int J Nanomedicine       Date:  2010-09-20

9.  Acetaldehyde accelerates HCV-induced impairment of innate immunity by suppressing methylation reactions in liver cells.

Authors:  Murali Ganesan; Jinjin Zhang; Tatiana Bronich; Larisa I Poluektova; Terrence M Donohue; Dean J Tuma; Kusum K Kharbanda; Natalia A Osna
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

10.  Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes.

Authors:  Ying Shan; Jianyu Zheng; Richard W Lambrecht; Herbert L Bonkovsky
Journal:  Gastroenterology       Date:  2007-08-03       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.